Jonen, Switzerland

Dirk Weber

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aurealis Oy. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dirk Weber. Retrieved from https://idiyas.com/inventor/dirk-weber-wlee3v0v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dirk Weber - Innovator in Probiotic Bacteria

Introduction

Dirk Weber is a notable inventor based in Jonen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant probiotic bacteria. His work focuses on innovative solutions for treating inflammatory skin dysfunctions.

Latest Patents

Dirk Weber holds one patent for his invention related to recombinant probiotic bacteria. This invention is specifically designed for use in the treatment of inflammatory skin dysfunctions. The patent outlines a method for effectively treating such conditions, showcasing his commitment to advancing medical science.

Career Highlights

Dirk Weber is associated with Aurealis Oy, where he applies his expertise in biotechnology. His work at the company emphasizes the importance of innovative approaches to health and wellness. Through his research and development efforts, he aims to improve the quality of life for individuals suffering from skin disorders.

Collaborations

Dirk collaborates with talented professionals in his field, including Thomas Wirth and Juha Yrjänheikki. These partnerships enhance the research and development process, fostering a collaborative environment that drives innovation.

Conclusion

Dirk Weber's contributions to the field of probiotic bacteria represent a significant advancement in medical treatments for skin conditions. His dedication to innovation and collaboration continues to inspire progress in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…